✦ LIBER ✦

PSS28 Long-Term Improvement in Patient-Reported Outcomes After Transition From Methotrexate to Ustekinumab in Moderate to Severe Psoriasis: Transit Week 52 Results

✍ Scribed by Reich, K.; Puig, L.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J.F.; Kragballe, K.; Mistry, S.; Bergmans, P.; Thompson, G.; Barker, J.; Paul, C.

Book ID: 122288458
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 60 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.08.2075

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSS16 SUSTAINED IMPROVEMENT IN SKIN DISE

PSS16 SUSTAINED IMPROVEMENT IN SKIN DISEASE-SPECIFIC QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS RECEIVING USTEKINUMAB MAINTENANCE THERAPY: LONG TERM RESULTS FROM PHOENIX 1

✍ C Leonardi; K Papp; B Schenkel; N Zhao; N Yeilding; A Kimball 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Sustained improvement in skin disease–sp

Sustained improvement in skin disease–specific quality of life in patients with moderate to severe psoriasis receiving ustekinumab maintenance therapy: Long-term results from PHOENIX 1

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

One-year safety and efficacy of ustekinu

One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis

✍ Reich, K.; Puig, L.; Paul, C.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB

Impact of adalimumab treatment on health

Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis

✍ D. Revicki; M.K. Willian; J.-H. Saurat; K.A. Papp; J.-P. Ortonne; C. Sexton; A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB